Search results

For the journal "Transfusion"
 4 articles found

Search results

For the journal "Transfusion"
 4 articles found

 Chikungunya
Evaluation of assays for nucleic acid testing for the prevention of chikungunya and dengue virus transmission by blood transfusion

Published on 05/11/2024 |  Original article (Abstract)  | Pierre Gallian et al. | Transfusion 2024; 64(8): 1503-8 3 min.

Chikungunya virus (CHIKV) and dengue virus (DENV) are both enveloped RNA mosquito‐borne viruses belonging to Togaviridae and Flaviviridae families, respectively. DENV is distributed into four serotypes (DENV‐1, DENV‐2, DENV‐3, and DENV‐4) and CHIKV has...

 Malaria
Canadian Blood Services traceback investigation of a suspected case of transfusion‐transmitted malaria

Published on 02/04/2024 |  Original article (Abstract)  | Bryan Tordon et al. | Transfusion 2023; 63(10): 2001-6 3 min.

Canadian Blood Services serves as the exclusive Canadian blood operator outside the province of Quebec. Approximately 800,00–900,000 allogeneic blood donations are collected by Canadian Blood Services annually, with the majority of donations (92%) from repeat donors. Blood transfusion carries residual...

 Malaria
A novel mitigation strategy for the prevention of transfusion‐transmitted malaria

Published on 02/04/2024 |  Original article (Abstract)  | Laura Tonnetti et al. | Transfusion 2024; 64(1): 94-103 5 min.

Malaria is caused by several protozoan parasite species in the genus Plasmodium. The blood stage of infection is associated with malaria symptoms, ranging from mild fever to severe complications that can result in death. Diagnostic methods in endemic areas have traditionally relied on the microscopic...

 Hepatitis A
Hepatitis A virus (HAV) RNA detection in Polish blood donors and likely transmissions through blood components during the 2017–2019 epidemic

Published on 30/04/2023 |  Original article (Abstract)  | Ewa Sulkowska et al. | Transfusion 2023; 63(2): 349-59 5 min.

Hepatitis A virus (HAV) is a non‐enveloped RNA virus. In most cases, HAV infection in adults is either asymptomatic and self‐limited or with only moderate intensity clinical symptoms. In fewer than 0.5% of infected individuals, a fulminant presentation can develop, although even in these...